Bexagliflozin – evaluation of the clinical efficacy, safety profile and potential new applications of the SGLT2 inhibitor: a review of the literature

安全概况 医学 重症监护医学 计算机科学 药理学 不利影响
作者
Józef Muszyński
出处
期刊:Journal of Medical Science [Iran University of Medical Sciences]
卷期号:94 (2): e1226-e1226
标识
DOI:10.20883/medical.e1226
摘要

Introduction. Type 2 diabetes (T2DM) is a growing global health, social, and economic problem. T2DM is often accompanied by other diseases and is associated with complications such as kidney damage and cardiovascular diseases. The 21st century has seen a breakthrough in treating T2DM, including incretins and flozins. This review focuses on bexagliflozin, a new SGLT-2 inhibitor approved by the FDA for treating T2DM. The efficacy, safety, and potential benefits of new uses are analysed. Materials and methods. Sources were obtained using PubMed and Google Scholar, as well as Medline, with the keywords: bexagliflozin, EGT1442, new indications for bexagliflozin, and bexagliflozin trials. Results. Unlike other SGLT-2 inhibitors, bexagliflozin has a different molecular structure, which may increase its selectivity and efficacy. Preliminary results suggest that the drug may offer additional therapeutic benefits over other drugs in this group, particularly in the treatment of hypertension and cardiac arrhythmias. Studies are currently underway to investigate its potential use in the treatment of chronic kidney disease in children and sleep apnoea. Conclusions. Bexagliflozin shows promise as a treatment for type 2 diabetes, with additional potential benefits in treating other conditions. Although the drug is relatively new to the market, preliminary studies indicate that it may offer advantages over other SGLT-2 inhibitors in some areas. Nevertheless, further clinical trials are needed to further evaluate its efficacy compared to other therapies and its potential in a broader range of applications

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
CodeCraft的应助被journey采纳,获得10
1秒前
00hello00发布了新的文献求助10
1秒前
李周发布了新的文献求助10
1秒前
Ccc完成签到,获得积分10
1秒前
科研通AI6.3的应助被bear采纳,获得10
3秒前
thesky发布了新的文献求助10
3秒前
充电宝的应助被kalani采纳,获得10
3秒前
4秒前
4秒前
迷路的糜完成签到,获得积分10
4秒前
英俊的铭的应助被jqy采纳,获得10
4秒前
5秒前
neckerzhu完成签到,获得积分10
5秒前
lingrong完成签到,获得积分20
5秒前
6秒前
7秒前
7秒前
从容完成签到,获得积分10
7秒前
无花果的应助被俭朴外绣采纳,获得10
8秒前
8秒前
科研通AI6.3的应助被超级无敌采纳,获得10
8秒前
10秒前
shy完成签到,获得积分10
10秒前
10秒前
好心情发布了新的文献求助30
10秒前
Lucas的应助被科研通管家采纳,获得10
10秒前
大模型的应助被科研通管家采纳,获得10
10秒前
酷波er的应助被科研通管家采纳,获得10
11秒前
研友_VZG7GZ的应助被科研通管家采纳,获得10
11秒前
11秒前
田様的应助被科研通管家采纳,获得10
11秒前
11秒前
赘婿的应助被科研通管家采纳,获得10
11秒前
11秒前
科研通AI2S的应助被科研通管家采纳,获得30
11秒前
11秒前
酷波er的应助被科研通管家采纳,获得10
11秒前
neckerzhu发布了新的文献求助10
12秒前
12秒前
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8189302
求助须知:如何正确求助?哪些是违规求助? 9576666
关于积分的说明 21849295
捐赠科研通 7787245
什么是DOI,文献DOI怎么找? 3435521
关于科研通互助平台的介绍 2559748
邀请新用户注册赠送积分活动 2482509